Market Research Logo

Medivation, Inc. (MDVN) - Financial and Strategic SWOT Analysis Review

Medivation, Inc. (MDVN) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Medivation, Inc. (Medivation) is a biopharmaceutical company which develops and commercializes medically innovative therapies to treat serious diseases. The company’s only product XTANDI developed for the treatment of patients with metastatic castration-resistant prostate cancer (CRPC). The company with collaboration with Astellas conducts studies for the treatment of enzalutamide in prostate cancer, advanced breast cancer, and hepatocellular carcinoma. The company offers its product to pharmaceuticals, biotechnology drugs and medical devices. It operates along with its subsidiaries in the US and in the UK. Medivation is headquartered in San Francisco, California, the US.

Medivation, Inc. Key Recent Developments

Jun 13, 2016: Sanofi Files Definitive Consent Solicitation To Remove And Replace Medivation’s Board
Jun 01, 2016: Sanofi Requests Record Date for Consent Solicitation to Remove and Replace Medivation’s Board of Directors
May 27, 2016: Medivation Files Preliminary Consent Revocation Statement
May 25, 2016: Sanofi Files Consent Solicitation To Remove and Replace Medivation’s Board
May 05, 2016: Sanofi Sends Letter to Medivation’s Board

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Medivation, Inc. - Key Facts
Medivation, Inc. - Key Employees
Medivation, Inc. - Key Employee Biographies
Medivation, Inc. - Major Products and Services
Medivation, Inc. - Pharmaceutical Pipeline Products Data
Medivation, Inc., Pipeline Products by Therapy Area
Medivation, Inc., Pipeline Products by Development Phase
Medivation, Inc. - History
Medivation, Inc. - Company Statement
Medivation, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Medivation, Inc. - Business Description
Medivation, Inc. - Corporate Strategy
Medivation, Inc. - SWOT Analysis
SWOT Analysis - Overview
Medivation, Inc. - Strengths
Strength - Collaboration With Astellas
Strength - Lead Product: Xtandi
Strength - Research and Development
Medivation, Inc. - Weaknesses
Weakness - Dependence on Third Party Manufacturers
Weakness - Termination of Development Programs
Medivation, Inc. - Opportunities
Opportunity - Acquisition of Talazoparib Product
Opportunity - Prostate Cancer Market
Opportunity - Strategic Partnerships
Medivation, Inc. - Threats
Threat - Competitive Environment
Threat - Stringent Government Regulations
Threat - Uncertain R&D outcomes
Medivation, Inc. - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Medivation, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Medivation, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Medivation, Inc., Recent Deals Summary
Section 5 – Company’s Recent Developments
Jun 13, 2016: Sanofi Files Definitive Consent Solicitation To Remove And Replace Medivation’s Board
Jun 01, 2016: Sanofi Requests Record Date for Consent Solicitation to Remove and Replace Medivation’s Board of Directors
May 27, 2016: Medivation Files Preliminary Consent Revocation Statement
May 25, 2016: Sanofi Files Consent Solicitation To Remove and Replace Medivation’s Board
May 05, 2016: Sanofi Sends Letter to Medivation’s Board
May 05, 2016: Medivation Reports First Quarter 2016 Financial Results
Mar 28, 2016: Jennifer Jarrett to Join Medivation as Chief Financial Officer
Feb 25, 2016: Medivation Reports Fourth Quarter and Full Year 2015 Financial Results and Provides 2016 Financial Guidance
Jan 11, 2016: Medivation Names Marion McCourt Chief Operating Officer
Nov 05, 2015: Medivation Reports Third Quarter 2015 Financial Results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Medivation, Inc., Key Facts
Medivation, Inc., Key Employees
Medivation, Inc., Key Employee Biographies
Medivation, Inc., Major Products and Services
Medivation, Inc., Number of Pipeline Products by Therapy Area
Medivation, Inc., Number of Pipeline Products by Development Stage
Medivation, Inc., Pipeline Products By Therapy Area and Development Phase
Medivation, Inc., History
Medivation, Inc., Subsidiaries
Medivation, Inc., Key Competitors
Medivation, Inc., Ratios based on current share price
Medivation, Inc., Annual Ratios
Medivation, Inc., Interim Ratios
Medivation, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Medivation, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Medivation, Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Medivation, Inc., Pipeline Products by Therapy Area
Medivation, Inc., Pipeline Products by Development Phase
Medivation, Inc., Performance Chart (2011 - 2015)
Medivation, Inc., Ratio Charts
Medivation, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Medivation, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report